Novo Nordisk A/S

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Sales (31 Dec 2018):

17,722.20M

EBITDA (31 Dec 2018):

8,109.50M

Number of employees:

42,672

Offtacker in projects

www.novonordisk.com

Novo Alle
Bagsvaerd, 2880
Denmark

About

The database of Corporate PPA deals. Details about corporates, that buy green energy, renewable energy projects, it's owners and developers.'

Latest Deals

Top Offtackers

Our Contacts

795 Folsom Ave, Suite 600,
San Francisco, CA 94107 795

info@corporate.energy
www.corporate.energy